In previous studies employing interferons (IFNs) in the treatment of chronic hepatitis C, there have been few reliable predictors of sustained responses. We retrospectively evaluated the predictive value of hepatitis C virus (HCV)-RNA measurements in the first few months during consensus interferon
Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C
β Scribed by SHINICHI KAKUMU; TOSHIYUKI AIYAMA; AKIHIKO OKUMURA; KAZUO IWATA; TETSUYA ISHIKAWA; KENTARO YOSHIOKA
- Book ID
- 108949462
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 460 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
CORRESPONDENCE 1287 tive anions determine the potential for crystal precipi-though the location within the stone is not identified. Thus, their data would seem to confirm our findings tation within bile. Certain disease states predispose and be in conflict with the statement in their letter to supe
TAKA0 TSUJI,~ SADAHITO SHIN,2 MASASHI TA"03, MICKEY s. URDEA,4 AND JANICE A. KOLBERG4 To clarify the viral factors that may predict the therapeutic effect of interferon (IFN) in chronic hepatitis C (CHC) patients, we investigated the quantitative serum hepatitis C virus (HCV) RNA level, genotype, a
Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months following suspension of interferon-β£ (IFN-β£) therapy reflect definitive viral clearance in patients with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information on this topic, HCV RN
## Abstract Serum hepatitis C virus (HCV) RNA level has been shown to be a good predictor of subsequent response to interferonβΞ± (IFN) therapy in US patients in whom genotype 1a/1b are both predominant. To determine whether serum HCV RNA level is a predictor of subsequent response to IFN in Japanes
## Abstract Studies were undertaken to investigate whether interferon therapy could induce hepatitis C virus (HCV) carriage with normal serum alanine aminotransferase (ALT) values using an assay that combined reverse transcription and polymerase chain reaction. The subjects studied were 53 patients